Bone marrow mononuclear cells from AML patients expressing CD36 are less susceptible to chemotherapeutic agents such as cytosine arabinoside (Ara-C) compared to cells that do not express CD36,28 demonstrating that CD36 expression interferes with chemotherapy. Here, CD36 is linked to acute myeloid leukemia.